Mianserin reduces plasma levels of beta-endorphin immunoreactivity in depressed patients.
作者信息
Drago F, Wiegant V M, Sapienza G, Aguglia E, Rapisarda V, Scapagnini U
出版信息
Experientia. 1982 Jun 15;38(6):685-6. doi: 10.1007/BF01964095.
PMID:6286338
Abstract
摘要
相似文献
1
Mianserin reduces plasma levels of beta-endorphin immunoreactivity in depressed patients.米安色林可降低抑郁症患者血浆中β-内啡肽免疫反应性水平。
Experientia. 1982 Jun 15;38(6):685-6. doi: 10.1007/BF01964095.
2
Double blind test with mianserin versus chlorimipramine.
Adv Biochem Psychopharmacol. 1982;32:141-9.
3
[Treatment of depressed out-patients with mianserin (author's transl)].
Schweiz Rundsch Med Prax. 1979 Jul 24;68(30):978-80.
4
[Comparison of the effects of lofepramin and mianserin in depressed patients in a double blind trial].
Int Pharmacopsychiatry. 1979;14(6):310-8.
5
Mianserin hydrochloride: a novel antidepressant.盐酸米安色林：一种新型抗抑郁药。
Br J Psychiatry. 1976 Oct;129:342-5. doi: 10.1192/bjp.129.4.342.
6
[Treatment of depression. Comparative study on the effects of mianserin (Tolvin) and amitriptyline].
Ther Ggw. 1979 May;118(5):806-18.
7
[Mianserin (Tolvin) in the management of glaucoma patients with depression].
Med Welt. 1978 Oct 6;29(40):1582-4.
8
Electroencephalogram study of mianserin in depressed patients.米安色林对抑郁症患者的脑电图研究。
Br J Clin Pharmacol. 1978;5 Suppl 1(Suppl 1):43S-47S.
9
[Mianserin and imipramin in depressive conditions (author's transl)].
Cesk Psychiatr. 1977 Aug;73(4):234-8.
10
The use of mianserin in the treatment of depression.
S Afr Med J. 1980 Jun 7;57(23):971-2.
引用本文的文献
1
Dissociation between CSF and plasma B-endorphin in major depressive disorders: evidence for a different regulation.重度抑郁症患者脑脊液与血浆β-内啡肽的解离：不同调节的证据
J Endocrinol Invest. 1986 Feb;9(1):11-4. doi: 10.1007/BF03348054.
2
Psychoneuroendocrine research in depression. I. Hormone levels of different neuroendocrine axes and the dexamethasone suppression test.抑郁症的心理神经内分泌研究。I. 不同神经内分泌轴的激素水平及地塞米松抑制试验。
J Neural Transm. 1989;75(3):167-78. doi: 10.1007/BF01258628.
本文引用的文献
1
Increased CSF levels of endorphines in chronic psychosis.慢性精神病患者脑脊液中内啡肽水平升高。
Neurosci Lett. 1976 Oct;3(3):157-62. doi: 10.1016/0304-3940(76)90086-0.
2
Cerebrospinal fluid endorphins in schizophrenia.
Acta Psychiatr Scand. 1980 May;61(5):395-403. doi: 10.1111/j.1600-0447.1980.tb00878.x.
3
International reliability and communicability of a rating scale for depression.一种抑郁症评定量表的国际可靠性和可传播性。
Psychol Med. 1973 Nov;3(4):458-65. doi: 10.1017/s003329170005426x.
4
Clinical and EEG effects of GB-94, a "tetracyclic" antidepressant (EEG model in discovery of a new psychotropic drug).“四环”类抗抑郁药GB - 94的临床及脑电图效应（新型精神药物发现中的脑电图模型）
Curr Ther Res Clin Exp. 1972 Jul;14(7):395-413.
5
Vasopressin in cerebrospinal fluid and plasma of man, dog, and rat.人、狗和大鼠脑脊液及血浆中的血管加压素。
Am J Physiol. 1978 May;234(5):E463-7. doi: 10.1152/ajpendo.1978.234.5.E463.
6
Naloxone (Narcan) treatment in depression: clinical observations and effects on CSF endorphins and monoamine metabolites.纳洛酮（纳曲酮）治疗抑郁症：临床观察及其对脑脊液内啡肽和单胺代谢产物的影响
Psychopharmacology (Berl). 1977 Aug 31;54(1):31-3. doi: 10.1007/BF00426537.
7
Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.米安色林：其药理特性及对抑郁症治疗效果的综述
Drugs. 1978 Oct;16(4):273-301. doi: 10.2165/00003495-197816040-00001.
8
Systemic administration of beta-endorphin: potent hypotensive effect involving a serotonergic pathway.β-内啡肽的全身给药：涉及5-羟色胺能通路的强效降压作用。
Proc Natl Acad Sci U S A. 1978 Dec;75(12):6240-2. doi: 10.1073/pnas.75.12.6240.
Zotero 插件